| Factor Information | |
|---|---|
| Data ID | 2889 |
| Factor | Preprocedure factors: Prostaglandin maximum dose |
| Description | Earlier gestational age (< 37 wks), lower maximum dose of prostaglandin infusion, and unexpected readmission to the intensive care unit were statistically associated with NEC (p = .009, 0.02, and 0.04, respectively). |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To investigate the prevalence of necrotizing enterocolitis (NEC) in neonates undergoing the Stage I hybrid procedure for palliation of complex congenital heart disease (CHD). |
| p Value | 0.02 |
| Conclusion | Earlier gestational age (< 37 wks), lower maximum dose of prostaglandin infusion, and unexpected readmission to the intensive care unit were statistically associated with NEC (p = .009, 0.02, and 0.04, respectively). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 636 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | HLHS/DORV, DORV, IAA/AVSD/TA, IAA/DILV/IAA, VSD/TA |
| Reference | |
|---|---|
| PMID | 20453698 |
| Year | 2011 |
| Title | Necrotizing enterocolitis in neonates undergoing the hybrid approach to complex congenital heart disease |
| Sample | ||
|---|---|---|
| Population | neonates | |
| Source | Retrospective chart review | |
| Region | OH, USA | |
| Method | Demographic, perinatal, perioperative, clinical, and procedural data were collected. | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | the hybrid procedure for palliation of complex CHD | |
| Group | patients with NEC(Treatment) | patients without NEC(Control) |
| Number | 8 | 65 |
| Age | 26 (18–28) years | 24 (17–40) years |
| Gender (Male: Female) | 5:3 | 39:26 |
| Marker Level | 0.02 (0.01–0.05) ug/kg/min | 0.03 (0.01–0.2) ug/kg/min |
